Amrutanjan Health Care Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2016 • OTC Products: 86.4% • Beverages: 11.6% • Chemicals: 1.3%
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 26.3%
- Company has consistently been profitable over the last 5 years
- Operating margins have improved to 18.6% from 14.9%
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.18x)
CONS
- Promoter holding has decreased over last 2 years: -4.1pp
- Expensive relative to growth - PEG of 2.5
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | 1864.00 | 36.98 | 447236.04 | 0.86 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| DIVISLAB | 9405.00 | 85.36 | 249673.20 | 0.32 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| TORNTPHARM | 4928.40 | 85.95 | 187460.49 | 0.77 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| ZYDUSLIFE | 1118.00 | 24.71 | 111520.93 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| CIPLA | 1380.00 | 33.08 | 111484.47 | 0.94 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| LAURUSLABS | 1936.00 | 95.67 | 104604.45 | 0.10 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| AUROPHARMA | 1669.00 | 25.87 | 96030.57 | 0.24 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| DRREDDY | 1140.80 | 29.55 | 95220.28 | 0.70 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| LUPIN | 2075.00 | 17.16 | 94882.67 | 0.87 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| MANKIND | 2246.00 | 45.42 | 92769.93 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| GLENMARK | 2417.00 | 37.94 | 68213.70 | 0.10 | 482.83 | 927.88 | 4018.48 | 31.35 | 20.35 | 20.03 |
| AMRUTANJAN | 493.80 | 67.52 | 1427.61 | 0.99 | 4.37 | -47.46 | 102.97 | 9.48 | 22.46 | 6.06 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|
| 105 | 143 | 138 | 142 | 167 | 187 | |
| 92 | 125 | 120 | 121 | 143 | 156 | |
| Operating Profit | 13 | 18 | 17 | 21 | 24 | 31 |
| OPM % | 12.50% | 12.73% | 12.65% | 14.75% | 14.15% | 16.49% |
| 5 | 4 | 4 | 4 | 4 | 6 | |
| Interest | 1 | 3 | 2 | 2 | 1 | 0 |
| Depreciation | 2 | 4 | 4 | 4 | 3 | 3 |
| Profit before Tax | 15 | 16 | 15 | 19 | 24 | 33 |
| Tax % | 33.61% | 38.98% | 34.62% | 35.79% | 38.28% | 37.05% |
| Net Profit | 10 | 10 | 10 | 12 | 15 | 21 |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout % | 44.51% | 45.51% | 43.34% | 37.58% | 34.32% | 27.35% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 12%
- 3 Years:
- 11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 15%
- 3 Years:
- 27%
STOCK PRICE CAGR
- 10 Years:
- 9%
- 5 Years:
- -7%
- 3 Years:
- -8%
- 1 Year:
- -35%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 15%
- 3 Years:
- 17%
- Last Year:
- 20%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 |
| 98 | 74 | 79 | 86 | 92 | 106 | |
| 30 | 21 | 16 | 8 | 3 | 3 | |
| Trade Payables | 7 | 10 | 9 | 7 | 8 | 9 |
| 18 | 16 | 18 | 16 | 18 | 20 | |
| Total Liabilities | 157 | 124 | 124 | 120 | 124 | 140 |
| 52 | 33 | 30 | 27 | 24 | 29 | |
| Capital Work in Progress | 0 | 0 | 1 | 1 | 4 | 1 |
| 42 | 29 | 25 | 9 | 9 | 9 | |
| 10 | 13 | 10 | 9 | 9 | 9 | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Bank | 24 | 15 | 15 | 35 | 38 | 48 |
| 27 | 34 | 44 | 39 | 40 | 45 | |
| Total Assets | 157 | 124 | 124 | 120 | 124 | 140 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|
| 10 | 9 | 14 | 25 | 28 | 32 | |
| Cash from Investing | -29 | 14 | 8 | 16 | -5 | 4 |
| Cash from Financing | 20 | -27 | -14 | -14 | -12 | -13 |
| -4 | -9 | 2 | 20 | 1 | 12 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding 'BRSR for the FY 2025-26'.
2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026
2026-08-12 - Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
2026-08-11 - Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.
2026-08-11 - Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Commencement of commercial production/operations
2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Credit Rating
2026-08-01 - Amrutanjan Health Care Limited has informed the Exchange about Action(s) taken or orders passed
2026-07-08 - Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
News
Recent coverage and analyst commentary for AMRUTANJAN
Loading news…
AI Stock Analyst
Amrutanjan Health Care Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account